Clorox Co (NYSE:CLX) SVP Michael R. Costello sold 6,882 shares of the firm’s stock in a transaction dated Thursday, November 15th. The stock was sold at an average price of $160.08, for a total transaction of $1,101,670.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Shares of NYSE CLX opened at $162.02 on Monday. The company has a debt-to-equity ratio of 3.38, a current ratio of 1.07 and a quick ratio of 0.65. The stock has a market cap of $20.68 billion, a P/E ratio of 27.55, a price-to-earnings-growth ratio of 3.98 and a beta of 0.28. Clorox Co has a 1 year low of $113.57 and a 1 year high of $162.99.
Clorox (NYSE:CLX) last issued its earnings results on Wednesday, October 31st. The company reported $1.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.59 by $0.03. The business had revenue of $1.56 billion during the quarter, compared to analysts’ expectations of $1.53 billion. Clorox had a net margin of 13.59% and a return on equity of 102.65%. The business’s revenue for the quarter was up 4.2% compared to the same quarter last year. During the same period in the previous year, the company earned $1.46 earnings per share. As a group, research analysts forecast that Clorox Co will post 6.31 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, February 8th. Shareholders of record on Wednesday, January 23rd will be issued a $0.96 dividend. The ex-dividend date is Tuesday, January 22nd. This represents a $3.84 annualized dividend and a yield of 2.37%. Clorox’s dividend payout ratio (DPR) is presently 61.34%.
Institutional investors have recently modified their holdings of the business. Berkshire Asset Management LLC PA raised its holdings in Clorox by 17.6% in the third quarter. Berkshire Asset Management LLC PA now owns 3,119 shares of the company’s stock worth $469,000 after buying an additional 467 shares during the last quarter. Carillon Tower Advisers Inc. raised its holdings in Clorox by 82.8% in the second quarter. Carillon Tower Advisers Inc. now owns 109,150 shares of the company’s stock worth $14,763,000 after buying an additional 49,450 shares during the last quarter. Legacy Advisors LLC purchased a new position in Clorox in the third quarter worth about $150,000. Victory Capital Management Inc. raised its holdings in Clorox by 0.4% in the second quarter. Victory Capital Management Inc. now owns 105,329 shares of the company’s stock worth $14,246,000 after buying an additional 456 shares during the last quarter. Finally, Raymond James Financial Services Advisors Inc. raised its holdings in Clorox by 7.2% in the second quarter. Raymond James Financial Services Advisors Inc. now owns 63,730 shares of the company’s stock worth $8,620,000 after buying an additional 4,281 shares during the last quarter. 76.33% of the stock is owned by institutional investors and hedge funds.
Several equities research analysts have recently commented on the stock. Zacks Investment Research reaffirmed a “sell” rating on shares of Clorox in a research report on Monday, November 12th. Citigroup raised their target price on shares of Clorox from $149.00 to $153.00 and gave the stock a “neutral” rating in a research report on Friday, November 2nd. Barclays set a $138.00 target price on shares of Clorox and gave the stock a “hold” rating in a research report on Thursday, November 1st. BMO Capital Markets raised their target price on shares of Clorox from $153.00 to $165.00 and gave the stock a “buy” rating in a research report on Friday, November 2nd. Finally, Wells Fargo & Co reaffirmed a “hold” rating on shares of Clorox in a research report on Wednesday, October 31st. Five equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $141.64.
TRADEMARK VIOLATION NOTICE: This piece of content was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/11/19/insider-selling-clorox-co-clx-svp-sells-1101670-56-in-stock.html.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Article: What is the Ex-Dividend Date in Investing?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.